Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer.
Turpin E, Bièche I, Bertheau P, Plassa LF, Lerebours F, de Roquancourt A, Olivi M, Espié M, Marty M, Lidereau R, Vidaud M, de Thé H.
Turpin E, et al. Among authors: lidereau r.
Oncogene. 2002 Oct 24;21(49):7593-7. doi: 10.1038/sj.onc.1205932.
Oncogene. 2002.
PMID: 12386822